Clinical Trials Logo

Lice Infestations clinical trials

View clinical trials related to Lice Infestations.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06057506 Recruiting - Clinical trials for Head Lice Infestation

Comparative Study for the Evaluation of Two Medical Devices on the Treatment of Head Lice Infestation

Start date: August 21, 2023
Phase: N/A
Study type: Interventional

Pediculosis capitis or head lice infestation is a human medical condition caused by the infestation of the hair by the parasitic insect Pediculus humanus capitis (human head lice). The most common symptom of infestation is pruritus (itching) on the head which normally intensifies 3 to 4 weeks after the initial infestation. The test items have been developed with the ambition to offer a complete head lice treatment, whilst also offering ultimative convenience in use - making treatment of head lice infestation easy, and effective in few minutes. The main objective of this clinical study is to confirm the efficacy on head lice treatment of two Medical Devices, already in market.

NCT ID: NCT05565820 Recruiting - Head Lice Clinical Trials

A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation

Start date: December 15, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of Vamousse Spray 'n' Go, compared to a 1% Permethrin control shampoo, in the treatment of head lice.

NCT ID: NCT05379114 Recruiting - Head Lice Clinical Trials

Comparative Study for the Evaluation of a New Medical Device on the Treatment of Head Lice Infestation

Start date: May 18, 2022
Phase: N/A
Study type: Interventional

Pediculosis capitis or head lice infestation is a human medical condition caused by the infestation of the hair by the parasitic insect Pediculus humanus capitis (human head lice). The most common symptom of infestation is pruritus (itching) on the head which normally intensifies 3 to 4 weeks after the initial infestation. The test item has been developed with the ambition to offer a complete head lice treatment, whilst also offering ultimate convenience in use - making treatment of head lice infestation easy, and effective in few minutes. The objectives of this clinical study are to assess the efficacy and the safety of a new Medical Device for lice infestation treatment compared to a comparator device, already in market.

NCT ID: NCT05378477 Recruiting - Head Lice Clinical Trials

A Clinical Trial to Evaluate Efficacy and Safety of a New Suffocating Head Lice Product.

Start date: January 17, 2022
Phase: N/A
Study type: Interventional

The present study is set-up to compare in vivo clinical performance and safety of the test product (X92001752) versus 3 other pediculicides (2 medical devices and 1 conventional pesticide).

NCT ID: NCT04878276 Recruiting - Pediculosis Capitis Clinical Trials

Comparative Head Lice Therapy With Dimet 5® vs. Hedrin® Once

VEKODIH
Start date: May 17, 2021
Phase:
Study type: Observational

Randomized, investigator-blinded, controlled, multicenter comparative study on the treatment of acute head lice infestation in children with 2 dimeticone preparations with different application times and compositions: Dimet 5® (100% dimeticone) versus Hedrin® Once Liquid Gel (4% dimeticone + nerolidol) with treatment success assessment via freedom from infestation of live head lice at final examination at V2, i.e. day 19 after first treatment.

NCT ID: NCT02569580 Recruiting - Lice Clinical Trials

Effectiveness of "No More" Anti-lice Medical Device to Kill Lice and Lice Eggs

Start date: October 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine effectiveness of an Anti-lice treatment using the medical device "No More" which is designed to kill lice and lice eggs on the head.